Adalynn Harris
President & Chief Executive Officer Equity Bridge
Seminars
Wednesday 5th November 2025
Laying Out Regulatory Requirements & Strategies to Achieve Representative D&I in ADC Clinical Trials
2:00 pm
- Explaining clinical trial processes and stressing the importance of regulatory requirements for clinical trial D&I
- Breaking down FDORA requirements and the D&I landscape in the US to understand impact on clinical trial recruitment and study
- Assessing differing strategies to achieve representative D&I across populations and locations
